This paper is in the following e-collection/theme issue:

Scoping Review Protocols (258) RCTs - Protocols/Proposals (eHealth) (682) Diabetes (267) Diabetes Technology Around the World (33) mHealth for Treatment Adherence (476)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77587, first published .
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol

Authors of this article:

Tooba Laeeq1 Author Orcid Image ;   Ayesha Mehak Kamal2 Author Orcid Image ;   Arbab Burhan Uddin Kasi3 Author Orcid Image ;   Umm E Salma Shabbar Banatwala2 Author Orcid Image ;   Aniqa Baloch2 Author Orcid Image ;   Roberto Sagaribay4 Author Orcid Image ;   Vidhani Goel4, 5 Author Orcid Image ;   Aditi Singh1 Author Orcid Image ;   Kavita Batra4, 6 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Tooba Laeeq   1 , MD ;   Ayesha Mehak Kamal   2 ;   Arbab Burhan Uddin Kasi   3 ;   Umm E Salma Shabbar Banatwala   2 ;   Aniqa Baloch   2 ;   Roberto Sagaribay   4 , PhD ;   Vidhani Goel   4, 5 , BS ;   Aditi Singh   1 , MD ;   Kavita Batra   4, 6 , PhD

1 Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, NV, United States

2 Dow University of Health Sciences, New Labour Colony Nanakwara, Karachi, Pakistan

3 Mass General Brigham, Boston, MA, United States

4 Office of Research, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, NV, United States

5 School of Public Health, University of Nevada, Las Vegas, NV, United States

6 Department of Medical Education, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, NV, United States

Corresponding Author:

  • Tooba Laeeq, MD
  • Department of Internal Medicine
  • Kirk Kerkorian School of Medicine at UNLV, University of Nevada
  • 9850 S Maryland PKWY
  • Las Vegas, NV 89154
  • United States
  • Phone: 1 7028950200
  • Email: tooba.laeeq@unlv.edu